37
Haemostatic cardiovascular risk Haemostatic cardiovascular risk factors: complementary effects of factors: complementary effects of red wine and mediterranean diet in red wine and mediterranean diet in young population. young population. Diego Mezzano, M.D. Diego Mezzano, M.D. Department of Department of Hematology-Oncology Hematology-Oncology School of Medicine School of Medicine Talca, Agosto 22, 2006

Haemostatic cardiovascular risk factors: complementary effects of red wine and mediterranean diet in young population. Diego Mezzano, M.D. Department of

Embed Size (px)

Citation preview

Haemostatic cardiovascular risk factors: Haemostatic cardiovascular risk factors: complementary effects of red wine and complementary effects of red wine and mediterranean diet in young population.mediterranean diet in young population.

Diego Mezzano, M.D. Diego Mezzano, M.D. Department of Hematology-Oncology Department of Hematology-Oncology School of Medicine School of Medicine

P. Catholic P. Catholic University of ChileUniversity of Chile

Talca, Agosto 22, 2006

ObjectivesObjectives

1.1. To compare the effect of an alcohol-free To compare the effect of an alcohol-free Mediterranean-type diet and a High-fat diet on Mediterranean-type diet and a High-fat diet on haemostatic variables.haemostatic variables.

2.2. To test whether red wine supplementation To test whether red wine supplementation modifies these variables, independently of diet.modifies these variables, independently of diet.

Composition of DietsComposition of DietsMDMD HFDHFD

Total calories (kcal/day)Total calories (kcal/day) 25652565 25652565

Calories in protein (%)Calories in protein (%) 17.617.6 17.617.6

Calories in fat (%)Calories in fat (%) 27.327.3 39.939.9

Saturated fats (g/day)Saturated fats (g/day) 22.722.7 35.835.8

MUFA (g/day)MUFA (g/day) 37.937.9 35.535.5

PUFA (g/day)PUFA (g/day) 9.69.6 32.032.0

-3 FA (g/day)-3 FA (g/day) 1.641.64 0.960.96

Olive oil (mL/day)Olive oil (mL/day) 3232 00

Fruits, vegetables (g/day)Fruits, vegetables (g/day) 675675 246246

MD

MD + RED WINE MD

HFD HFD + RED WINE

HFD

0 30 60 90

GROUP MD

GROUP HFD

N = 21

N = 21

Diet Intervention Design

Comparison between MD and HFD Comparison between MD and HFD groups at T0groups at T0

Variable:Variable: MDMD HFDHFD p =p =

Age (years)Age (years) 21.2 21.2 1.7 1.7 22.6 22.6 4.5 4.5 0.210.21

Body mass index (kg/mBody mass index (kg/m22)) 23.4 23.4 2.0 2.0 23.7 23.7 2.5 2.5 0.570.57

Serum albumin (g/L)Serum albumin (g/L) 5.1 5.1 0.24 0.24 5.1 5.1 0.17 0.17 0.820.82

Blood hemoglobin (g/L)Blood hemoglobin (g/L) 151 151 7.5 7.5 152 152 8.7 8.7 0.600.60

Plasma cholesterol (mmol/L)Plasma cholesterol (mmol/L) 4.42 4.42 0.720.72

4.57 4.57 0.670.67

0.440.44

Triacylglycerides (mmol/L)Triacylglycerides (mmol/L) 1.13 1.13 0.570.57

1.05 1.05 0.560.56

0.590.59

Comparison between MD and HFD Comparison between MD and HFD groups at T0groups at T0

Variable:Variable: MDMD HFDHFD p =p =

Plasma Plasma -carotene (-carotene (mol/L)mol/L) 0.26 0.26 0.150.15

0.37 0.37 0.250.25

0.080.08

Plasma ascorbate (Plasma ascorbate (mol/L)mol/L) 54.7 54.7 15.015.0

53.5 53.5 10.910.9

0.780.78

Serum folate (nmol/L)Serum folate (nmol/L) 13.8 13.8 3.1 3.1 11.7 11.7 2.8 2.8 0.190.19

Eicosapentaenoic acid (%)Eicosapentaenoic acid (%) 1.20 1.20 0.560.56

0.93 0.93 0.440.44

0.190.19

Comparison between MD and HFD Comparison between MD and HFD groups after 30 daysgroups after 30 days

Variable:Variable: MDMD HFDHFD p =p =

Plasma Plasma -carotene (-carotene (mol/L)mol/L) 0.49 0.49 0.190.19

0.23 0.23 0.140.14

0.00010.0001

Plasma ascorbate (Plasma ascorbate (mol/L)mol/L) 55.9 55.9 11.211.2

29.7 29.7 8.9 8.9 0.00010.0001

Serum folate (nmol/L)Serum folate (nmol/L) 14.2 14.2 4.3 4.3 10.5 10.5 2.6 2.6 0.0020.002

Eicosapentaenoic acid (%)Eicosapentaenoic acid (%) 1.50 1.50 0.7 0.7 0.85 0.85 0.300.30

0.0010.001

Time [Days]

0 30 60 90

To

tal

ch

ole

ste

rol

(mg

/dL

)

0

50

100

150

200

HFDMD

Differential effects of diet and red Differential effects of diet and red wine on haemostatic CVRFwine on haemostatic CVRF

• Several haemostasis proteins which participate Several haemostasis proteins which participate in the generation, inhibition or removal of in the generation, inhibition or removal of fibrin, are either established or potential fibrin, are either established or potential CVRF.CVRF.

• Among them, plasma levels of fibrinogen, Among them, plasma levels of fibrinogen, factors VIIc and VIIIc, tPA and PAI-1.factors VIIc and VIIIc, tPA and PAI-1.

Days

0 30 60 90

Fib

rino

gen

(mg/

dL)

0

200

210

220

230

240

250

260

270

280

HFDMD

Days

0 30 60 90

Fac

tor

VIIc

(%

)

0

65

70

75

80

85

90

Days

0 30 60 90

Fac

tor

VIII

(%

)

0

50

55

60

65

70

75

80

85

90

Days

0 30 60 90

AT

III (

%)

0

120

125

130

135

140

145

150

155

P=0.03

P=0.001

P=0.034

P=0.05

P=0.006 P=0.01

Days0 30 60 90

Pro

tein

S (

%)

0

70

75

80

85

90

HFDMD

p = 0.013

Days0 30 60 90

tPA

-Ag

(n

g/d

L)

0

2

3

4

5

6

7

HFDMD

p = 0.01

Days

0 30 60 90

PA

I-A

g (

ng

/dL

)

0

20

25

30

35

40

45

HFDMD

p = 0.0003

Differential effects of diet and red wine Differential effects of diet and red wine on primary hemostasis variableson primary hemostasis variables

• Primary hemostasis: processes that mediate Primary hemostasis: processes that mediate interaction of interaction of plateletsplatelets with the with the vessel wallvessel wall..

• Platelet function is an essential phenomenon in the Platelet function is an essential phenomenon in the pathogenesis of arterial cardiovascular events, and pathogenesis of arterial cardiovascular events, and pharmacological agents that decrease platelet-vessel pharmacological agents that decrease platelet-vessel wall interaction are pivotal in preventing and/or wall interaction are pivotal in preventing and/or treating these accidents.treating these accidents.

• Some important variables of primary hemostasis Some important variables of primary hemostasis include bleeding time, plasma vWF levels and include bleeding time, plasma vWF levels and platelet aggregation and secretion.platelet aggregation and secretion.

Time [days]

0 30 60 90

Ble

ed

ing

tim

e [m

in]

0

2

4

6

8

10

MDHFD

p = 0.017

Time [days]

0 30 60 90

Pla

sma

von

Will

ebra

nd fa

ctor

[%]

0

60

70

80

90

100

110

120

130

HFDMD

Days

0 30 60 90

Pla

tele

t agg

rega

tion/

secr

etio

n (%

)4

M A

DP

0

10

20

30

40

50

60

Aggreg HFDAggreg MDSecret HFDSecret MD

ADP 4M

p = 0.07

Days

0 30 60 90 Pla

tele

t a

gg

reg

atio

n/s

ecr

etio

n (

%)

8

M A

DP

0

10

20

30

40

50

60

70

80

Aggreg HFDAggreg MDSecret HFDSecret MD

ADP 8M

Days

0 30 60 90 Pla

tele

t agg

rega

tion/

secr

etio

n (%

)1

g/m

L co

llage

n

10

20

30

40

50

60

70

80Aggreg HFDAggreg MDSecret HFDSecret MD

p = 0.003

Collagen, 1g/mL

Days

0 30 60 90 Pla

tele

t agg

rega

tion/

secr

etio

n (%

)2

g/m

L co

llage

n

20

30

40

50

60

70

80

Aggreg HFDAggreg MDSecret HFDSecret MD

p = 0.005

p = 0.013

Collagen, 2g/mL

Conclusions. 1.Conclusions. 1.

1.1. Intake of a MD, compared with a HFD, was associated Intake of a MD, compared with a HFD, was associated with an overall improvement in haemostatic CV risk with an overall improvement in haemostatic CV risk factors: lower plasma fibrinogen and factors VIIc and factors: lower plasma fibrinogen and factors VIIc and VIIIc, and higher levels of protein S. Red wine VIIIc, and higher levels of protein S. Red wine supplementation in both diets resulted in further decrease supplementation in both diets resulted in further decrease in plasma fibrinogen and factor VIIc, but in increases in in plasma fibrinogen and factor VIIc, but in increases in PAI-1 and t-PAAg.PAI-1 and t-PAAg.

2.2. The longer BT in individuals on MD, independently of red The longer BT in individuals on MD, independently of red wine, denotes less interaction of platelets with the wine, denotes less interaction of platelets with the vascular wall, which could be beneficial from the point of vascular wall, which could be beneficial from the point of view of cardiovascular (CV) risk.view of cardiovascular (CV) risk.

Conclusions. 2.Conclusions. 2.

3.3. Moderate consumption of red wine results in a Moderate consumption of red wine results in a significant increase in significant increase in ex vivo ex vivo platelet aggregation platelet aggregation and secretion after stimulation with collagen, and secretion after stimulation with collagen, whereas no significant changes were observed whereas no significant changes were observed when platelets were challenged with other when platelets were challenged with other agonists.agonists.

4.4. Our observations denote that some of the Our observations denote that some of the beneficial effects of moderate red wine beneficial effects of moderate red wine consumption would be mediated by its favourable consumption would be mediated by its favourable influence on hemostatic CV risk factors and not on influence on hemostatic CV risk factors and not on inhibition of platelet responses. inhibition of platelet responses.

Complementary effects of Mediterranean diet and moderate Complementary effects of Mediterranean diet and moderate red wine intake on haemostatic cardiovascular risk factors.red wine intake on haemostatic cardiovascular risk factors. Mezzano D, Leighton F, Martínez C, Marshall G, Cuevas A, Castillo O, D, Leighton F, Martínez C, Marshall G, Cuevas A, Castillo O, Panes O, Muñoz B, Pérez DD, Mizón C, Rozowski J, San Martín A, Panes O, Muñoz B, Pérez DD, Mizón C, Rozowski J, San Martín A, Pereira J. Pereira J. Eur J Clin Nutr 2001; 55: 444-451.Eur J Clin Nutr 2001; 55: 444-451.

  

Mediterranean diet, but not red wine, is associated with beneficial changes on primary haemostasis.

Mezzano D, Leighton F, Strobel P, Martínez C, Marshall G, Cuevas A, Castillo O, Panes O, Muñoz B, Rozowski J, Pereira J.

Eur J Clin Nutr 2003; 57: 439-446.

Days

0 30 60 90

Fib

rin

og

en

(m

g/d

L)

0

200

210

220

230

240

250

260

270

280

HFDMD

p = 0.03

p = 0.001

Days

0 30 60 90

Fa

cto

r V

IIc

(%

)

0

65

70

75

80

85

90

HFDMD

p = 0.034

p = 0.05

Days

0 30 60 90

Fa

cto

r V

IIIc

(%

)

0

50

55

60

65

70

75

80

85

90

HFDMD

p = 0.006

Days

0 30 60 90

AT

III (

%)

0

120

125

130

135

140

145

150

155

HFDMD

p = 0.01

Days

0 30 60 90

Pro

tein

C (

%)

0

80

85

90

95

100

105

110

115HFDMD

Days

0 30 60 90

Pla

tele

t agg

rega

tion/

secr

etio

n (%

)8

M e

pine

phrin

0

10

20

30

40

50

60Aggreg HFDAggreg MDSecret HFDSecret MD

p = 0.02

Epinephrin 8M